Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
05 Feb 2025 |
DISS40 |
Compulsory strike-off action has been discontinued
|
|
|
04 Feb 2025 |
AA |
Total exemption full accounts made up to 31 December 2023
|
|
|
10 Dec 2024 |
GAZ1 |
First Gazette notice for compulsory strike-off
|
|
|
29 Jul 2024 |
CS01 |
Confirmation statement made on 29 July 2024 with no updates
|
|
|
12 Sep 2023 |
AA |
Total exemption full accounts made up to 31 December 2022
|
|
|
12 Sep 2023 |
TM01 |
Termination of appointment of Nicholas Andrew Ingrassia as a director on 3 August 2023
|
|
|
08 Aug 2023 |
AD01 |
Registered office address changed from 15 Ingestre Place London W1F 0DU United Kingdom to 6 Heddon Street London W1B 4BT on 8 August 2023
|
|
|
31 Jul 2023 |
CS01 |
Confirmation statement made on 29 July 2023 with no updates
|
|
|
02 Nov 2022 |
AA |
Total exemption full accounts made up to 31 December 2021
|
|
|
16 Sep 2022 |
AD01 |
Registered office address changed from Suite 1, 15 Ingestre Place London W1F 0DU England to 15 Ingestre Place London W1F 0DU on 16 September 2022
|
|
|
29 Jul 2022 |
CS01 |
Confirmation statement made on 29 July 2022 with no updates
|
|
|
14 Feb 2022 |
TM01 |
Termination of appointment of Kevin Francis Sheil as a director on 27 January 2022
|
|
|
05 Oct 2021 |
AA01 |
Current accounting period extended from 31 July 2021 to 31 December 2021
|
|
|
27 Aug 2021 |
AD01 |
Registered office address changed from 7-9 Swallow Street London W1B 4DE United Kingdom to Suite 1, 15 Ingestre Place London W1F 0DU on 27 August 2021
|
|
|
09 Aug 2021 |
CS01 |
Confirmation statement made on 29 July 2021 with updates
|
|
|
09 Aug 2021 |
PSC07 |
Cessation of Apollon Formularies Inc as a person with significant control on 12 April 2021
|
|
|
09 Aug 2021 |
PSC07 |
Cessation of Roderick Claude Mcillree as a person with significant control on 12 April 2021
|
|
|
09 Aug 2021 |
PSC02 |
Notification of Apollon Formularies Plc as a person with significant control on 12 April 2021
|
|
|
18 May 2021 |
AA |
Total exemption full accounts made up to 31 July 2020
|
|
|
14 Mar 2021 |
AP01 |
Appointment of Mr Nicholas Andrew Ingrassia as a director on 19 January 2021
|
|
|
14 Mar 2021 |
AP01 |
Appointment of Mr Kevin Francis Sheil as a director on 17 November 2020
|
|
|
26 Nov 2020 |
TM01 |
Termination of appointment of Roderick Claude Mcillree as a director on 17 November 2020
|
|
|
19 Nov 2020 |
DISS40 |
Compulsory strike-off action has been discontinued
|
|
|
18 Nov 2020 |
AA |
Total exemption full accounts made up to 31 July 2019
|
|
|
17 Nov 2020 |
GAZ1 |
First Gazette notice for compulsory strike-off
|
|